Genentech Inc:企業の戦略的SWOT分析

◆英語タイトル:Genentech Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15787
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Genentech Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology, metabolism, primary care, neurology, virology, hematology and specialty care. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and other products. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Mar 11,2019 Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11,2019 Samsung Bioepis forms new alliance to expand in China
Feb 06,2019 Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24,2019 Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17,2019 PhRMA welcomes Genentech and Gilead Sciences to association

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Genentech Inc – Key Facts
Genentech Inc – Key Employees
Genentech Inc – Key Employee Biographies
Genentech Inc – Major Products and Services
Genentech Inc – History
Genentech Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Genentech Inc – Business Description
Genentech Inc – SWOT Analysis
SWOT Analysis – Overview
Genentech Inc – Strengths
Genentech Inc – Weaknesses
Genentech Inc – Opportunities
Genentech Inc – Threats
Genentech Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 11, 2019: Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11, 2019: Samsung Bioepis forms new alliance to expand in China
Feb 06, 2019: Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17, 2019: PhRMA welcomes Genentech and Gilead Sciences to association
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 28, 2018: Roche subsidiary Genentech to acquire Jecure Therapeutics
Oct 04, 2018: Positive Phase III Results for Baloxavir Marboxil in People at High Risk of Complications From Influenza to be Presented at IDWeek 2018
Sep 13, 2018: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis[Newswire : Healthcare-BW]
Jul 19, 2018: Genentech to present new data demonstrating the breadth and depth of its alzheimer’s program at the upcoming Alzheimer’s Association International Conference (AAIC)
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary

List of Figures
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Genentech Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fonterra Co-operative Group Ltd:企業のM&A・事業提携・投資動向
    Fonterra Co-operative Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fonterra Co-operative Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Union Investment Group:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Union Investment Group" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fo …
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Inter IKEA Systems B.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Inter IKEA Systems B.V. Mergers …
  • Grupo Isolux Corsan, S.A.:企業のM&A・提携動向(エネルギー分野)
    Summary Grupo Isolux Corsan, S.A. (Isolux) is an engineering and construction contractors. It has expertise in concession, energy, infrastructure, industry and environment, installation and transmission and distribution, business areas. The company offers contracting services related to the construc …
  • Towergate Financial (Group) Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Towergate Financial (Group) Ltd …
  • Sharps Compliance Corp. (SMED):企業の財務及び戦略的SWOT分析
    Summary Sharps Compliance Corp. (Sharps) is a healthcare waste solution company that develops and provides medical disposal solutions. The company’s products include sharps disposal systems, public sharps safety, unused medication disposal, sharps container disposal and sharp containers. It provides …
  • Tesaro Inc (TSRO)-製薬・医療分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Stantec Inc (STN)-エネルギー分野:企業M&A・提携分析
    Summary Stantec Inc. (Stantec) is a consulting services company offering architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engineering, landscape architectu …
  • NovoPolymers NV:企業のM&A・提携動向(発電分野)
    Summary NovoPolymers NV (NovoPolymers) is an encapsulant solution provider that develops and produces environmentally sound sheets and films for solar cell industry. The company’s products include NovoVellum optima series, NovoVellum optima MF01, NovoVellum optima FC03, NovoVellum HiPo series and No …
  • BerryPharma AG:企業の戦略・SWOT・財務分析
    SummaryBerryPharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • University of Iowa:企業のM&A・提携動向(医療分野)
    Summary University of Iowa (UI) is a research university that offers undergraduate, graduate and professional degrees. The university offers programs such as American studies, anthropology, art and art history, biology, biomedical sciences, chemistry, cinematic arts, classics, communication sciences …
  • Medical Transcription Billing, Corp. (MTBC):企業のM&A・提携動向(医療機器分野)
    Summary Medical Transcription Billing, Corp. (Medical Transcription) is a healthcare IT company that develops and markets medical software products. The company offers products which include electronic health records, practice management software, patient engagement software and mHealth. Its Practic …
  • Orell Fussli Holding AG:企業の戦略・SWOT・財務分析
    SummaryOrell Fussli Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Ellex Medical Lasers Limited (ELX):企業のM&A・提携動向(医療機器分野)
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Hitachi Construction Machinery Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hitachi Construction Machinery …
  • ProMIS Neurosciences Inc (PMN):製薬・医療:M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • Manz AG (M5Z):企業の財務・戦略的SWOT分析
    Manz AG (M5Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Oramed Pharmaceuticals Inc (ORMP)-製薬・医療分野:企業M&A・提携分析
    Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique …
  • Mount Tam Biotechnologies Inc (MNTM):企業の財務・戦略的SWOT分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that offers development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆